Profile of Cervical Cancer Management with Radiation and Chemoradiation Therapy at The Radiotherapy Installation of RSUP Dr. Mohammad Hoesin Palembang

Wahyudi Nurhidayat; Dini Andriani; Lucky Taufika Yuhedi; Wahyu Diyana

doi:10.32532/jori.v15i1.165

Profile of Cervical Cancer Management with Radiation and Chemoradiation Therapy at The Radiotherapy Installation of RSUP Dr. Mohammad Hoesin Palembang

Wahyudi Nurhidayat, Dini Andriani, Lucky Taufika Yuhedi, Wahyu Diyana

Sari

Cervical cancer is a gynecologic malignancy that ranks as the second most common cancer affecting women, following breast cancer. Recommended therapy for locally advanced cervical cancer, according to PNPK (National Guidelines for Cancer Services) is chemoradiation or radiotherapy. The aim of this study is to present a comprehensive analysis of the management cervical cancer with chemoradiation and radiation therapy, which will allow for a comparison of outcomes, specifically the clinical tumor response and radiation-related side effects, in patients with locally advanced cervical cancer who received either radiation therapy alone or a combination of chemoradiation. This research is a retrospective observational study using our hospital database in 2022. SPSS was used for the data analysis. The study findings indicated a notable disparity between chemoradiation therapy and radiation alone in terms of treatment outcomes for patients with stage III cervical cancer, with a p-value of 0.011. The findings of this study indicate that the projected number of new cervical cancer cases at the RSMH Palembang Radiotherapy Installation in 2022 was 194 patients. The age ranged from 27 to 75 years, with an average age of 49.59 ± 9.29 years. A significant proportion, specifically 42%, of the domicile addresses of most patients originate from Palembang City and its surrounding areas. Stage III was the most advanced stage of patients, with a prevalence of 76%. The distribution of cervical cancer cell types was predominantly squamous cell carcinoma, accounting for approximately 80%, with adenocarcinoma comprising the remaining 20%. The overall efficacy of therapy for cervical cancer, regardless of the stage, was 63.5%.

Kata Kunci

Profile Cervical cancer; Chemoradiation; Radiation

Teks Lengkap:

PDF (English)

Referensi

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin [Internet]. 2021;71:209–49. Available from: https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21660

Badan Penelitian dan Pengembangan Kesehatan. Laporan Riset Kesehatan Dasar (RISKESDAS) tahun 2013 dalam bentuk angka [Internet]. Badan Penelitian dan Pengembangan Kesehatan, editor. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2013. Available from: https://repository.badankebijakan.kemkes.go.id/id/eprint/4428

World Health Organization (WHO). Cancer [Internet]. 2022 [cited 2022 Apr 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer

Surveillance Epidemiology and End Results Program (SEER). Cancer Stat Facts: Cervical Cancer [Internet]. National Cancer Institute (NCI). 2020 [cited 2022 Apr 1]. Available from: https://seer.cancer.gov/statfacts/html/cervix.html

Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran (PNPK) Tata Laksana Kanker Serviks [Internet]. Komite Penanggulangan Kanker Nasional, editor. Komite Penanggulangan Kanker Nasional. Jakarta: Kementerian Kesehatan Republik Indonesia; 2018. Available from: https://kemkes.go.id/id/pnpk-2018---tata-laksana-kanker-serviks

Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran (PNPK) Tata Laksana Kanker Serviks. Komite Penanggulangan Kanker Nasional, editor. Jakarta: Kementerian Kesehatan Republik Indonesia; 2016.

Andrijono, Purwoto G, Sekarutami SM, Handjari DR, Primariadewi, Nuhonni SA, et al. Panduan Praktik Klinis Kanker Serviks. 1.0.2018. Gondhowiardjo SA, editor. Jakarta: RSCM; 2018.

National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) - Cervical Cancer Version 1.2022. 1.2022. National Comprehensive Cancer Network (NCCN), editor. NCCN.org; 2022.

Beyzadeoglu M, Ozyigit G, Ebruli C. Basic Radiation Oncology [Internet]. Second Edition. Basic Radiation Oncology: Second Edition. Switzerland: Springer International Publishing; 2022. 1–522 p. Available from: https://link.springer.com/book/10.1007/978-3-030-87308-0

Klopp AH, Eifel PJ. Chemoradiotherapy for cervical cancer in 2010. Curr Oncol Rep [Internet]. 2011;13:77–85. Available from: https://pubmed.ncbi.nlm.nih.gov/21042887/

Datta NR, Stutz E, Liu M, Rogers S, Klingbiel D, Siebenhüner A, et al. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis. Gynecol Oncol [Internet]. 2017 [cited 2024 Jul 21];145:374–85. Available from: https://pubmed.ncbi.nlm.nih.gov/28188016/

Eifel PJ. Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol [Internet]. 2006 [cited 2024 Jul 21];16:177–85. Available from: https://pubmed.ncbi.nlm.nih.gov/16814159/

Amin Y, Mulawardhana P, Erawati D. Demografi, Respon Terapi dan Survival rate Pasien Kanker Serviks Stadium III-IVA yang Mendapat Kemoterapi Dilanjutkan Radioterapi. Majalah Obstetri & Ginekologi [Internet]. 2015;23:97–105. Available from: https://garuda.kemdikbud.go.id/documents/detail/467160

Anggraeni TD, Nuranna L, Sobur CS, Rahardja F, Hia CW, Utami TW, et al. Distribution of Age, Stage, and Histopathology of Cervical Cancer: A Retrospective Study on Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia, 2006-2010. Indonesian Journal of Obstetrics and Gynecology [Internet]. 2011 [cited 2022 Feb 14]; Available from: http://inajog.com/index.php/journal/article/view/218

Kato S, Ohno T, Thephamongkhol K, Chansilpa Y, Cao J, Xu X, et al. Long-term follow-up results of a multi-institutional phase 2 study of concurrent chemoradiation therapy for locally advanced cervical cancer in east and southeast Asia. Int J Radiat Oncol Biol Phys [Internet]. 2013;87:100–5. Available from: https://pubmed.ncbi.nlm.nih.gov/23920390/

Srinath A, Van Merode F, Rao SV, Pavlova M. Barriers to cervical cancer and breast cancer screening uptake in low- and middle-income countries: a systematic review. Health Policy Plan [Internet]. 2023;38:509–27. Available from: https://pubmed.ncbi.nlm.nih.gov/36525529/

Lasut E, Rarung M, Suparman E. Karakteristik Penderita Kanker Serviks di BLU RSUP Prof. Dr. R. D. Kandou. e-CliniC [Internet]. 2015;3:83–6. Available from: https://ejournal.unsrat.ac.id/v2/index.php/eclinic/article/view/6519

Legianawati D, Puspitasari IM, Suwantika AA, Kusumadjati A. Profil Penatalaksanaan Kanker Serviks Stadium IIB–IIIB dengan Terapi Radiasi dan Kemoradiasi di Rumah Sakit Umum Pusat Dr. Hasan Sadikin Bandung Periode Tahun 2015–2017. Indonesian Journal of Clinical Pharmacy [Internet]. 2019;8:205–16. Available from: https://jurnal.unpad.ac.id/ijcp/article/view/21795

Watulingas AM, Loho M, Wagey F, Manado SR, Obstetri B, Fakultas G, et al. Karakteristik penderita kanker serviks di RSUP Prof. Dr. R. D. Kandou Manado periode 1 Januari 2013 - 31 Desember 2015. e-CliniC [Internet]. 2016;4. Available from: https://ejournal.unsrat.ac.id/v3/index.php/eclinic/article/view/14477

Kurniawati L, Nurrochmah S, Katmawanti S. Hubungan Antara Tingkat Pendidikan, Status Pekerjaan dan Tingkat Pendapatan dengan Usia Perkawinan Pertama Wanita di Kelurahan Kotalama Kecamatan Kedungkandang Kota Malang. Preventia : The Indonesian Journal of Public Health [Internet]. 2016;1:210–9. Available from: https://journal2.um.ac.id/index.php/preventia/article/view/2748

Dwipoyono B, Nasdaldy N, Soemanadi S, Sjamsuddin S, Adisasmita A. Jenis Histologik dan Umur pada Kanker Serviks Uteri di Rumah Sakit Kanker “Dharmais.” Indonesian Journal of Cancer [Internet]. 2007;1. Available from: https://www.indonesianjournalofcancer.or.id/e-journal/index.php/ijoc/article/view/1/1

Williamson JF, Brenner DJ. Perez and Brady’s principles and practice of radiation oncology. Seventh edition. Halperin EC, Wazer DE, Perez CA, Brady LW, editors. Perez and Brady’s Principles and Practice of Radiation Oncology. Philadelphia ; Baltimore ; New York: Wolters Kluwer; 2018. 530–581 p.

Schorge JO, Schaffer J, Halvorson L, Hoffman B, Bradshaw K, Cunningham F. William Gynecology. 1st ed. Calver LE, editor. New York: McGraw-Hill Professional; 2008.

Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med [Internet]. 1999;340:1137–43. Available from: https://pubmed.ncbi.nlm.nih.gov/10202164/

Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med [Internet]. 1999;340:1144–53. Available from: https://pubmed.ncbi.nlm.nih.gov/10202165/

Eifel PJ. Concurrent chemotherapy and radiation: a major advance for women with cervical cancer. J Clin Oncol [Internet]. 1999;17:1334–5. Available from: https://pubmed.ncbi.nlm.nih.gov/10334515/

Ryu HS. Concurrent chemoradiotherapy in cervical cancer (a new paradigm in cervical cancer treatment). Yonsei Med J [Internet]. 2002;43:749–53. Available from: https://pubmed.ncbi.nlm.nih.gov/12497658/

Wang N, Guan QL, Wang K, Zhou X, Gao C, Yang HT, et al. Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis. Arch Gynecol Obstet [Internet]. 2011;283:103–8. Available from: https://pubmed.ncbi.nlm.nih.gov/20157716/

DOI: https://doi.org/10.32532/jori.v15i1.165 <